Study Details
Metastatic Ewing's Sarcoma Trial to Test Multiple Forms of Drug Combination Therapies
(IRB#: IRB_00192964)
For Patients who have been diagnosed with Ewing Sarcoma or Ewing-like Sarcoma. This study is being done to see if treatment of this cancer by using multiple forms of drug combination therapies will prevent cancer from worsening in children and young adult participants with this type of cancer. Participants in the study will receive study drugs that include chemotherapy and radiation at certain timepoints.
- All genders
- All Ages
- Volunteers with special conditions
- In Person
- Unpaid
Who can participate?
Gender: All genders
Age: All Ages
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Patients, in the opinion of their doctor, must be healthy enough to tolerate protocol therapy.
- Patients must have a new diagnosis of either widely metastatic Ewing sarcoma or metastatic CIC-rearranged sarcoma.
Exclusion Criteria
- Patients with localized disease or lung only metastases for Ewing sarcoma or localized disease for CIC-rearranged sarcomas.
- Patients with central nervous system (CNS) tumors (primary or metastatic) are not eligible.
Will I be paid for my time?
No
IRB#: IRB_00192964
PI: Matthew Dietz
Department: PEDIATRIC HEMATOLOGY/ONCOLOGY
Approval Date: 2026-06-01 19:33:00
Study Categories: Cancer Studies
Specialties: Pediatric Hematology & Oncology
I am Interested